Skip to main content
Uncategorized

Low-MOQ Cosmetics Manufacturing: What You Can Customize at 100, 500 and 1,000 Units

Quick Answer: What Changes at 100, 500 and 1,000 Units?

Order quantity does not buy the same customization at every manufacturer. It changes which production, filling, purchasing and decoration routes are commercially workable.

– **Around 100 units:** an eligible proven formula, stock packaging and a label or other low-setup branding route are usually the most practical combination.
– **Around 500 units:** brands may have more room for formula adjustments, packaging finishes, cartons and coordinated testing, subject to component and process minimums.
– **Around 1,000 units:** more direct decoration, color coordination and component sourcing options may become workable, but custom molds and highly specialized materials can still require higher commitments.

INHI publicly states that eligible ready-formula, custom-formula and selected custom-packaging projects can start from 100 units, subject to formula, materials and process feasibility. That is a project-entry point, not a promise that every feature is available at 100 units. Review INHI’s [ready-formula, custom-formula and full-service development routes](https://inhicosmetics.com/solutions/) before choosing a quantity.

## Low-MOQ Customization Decision Table

| Decision area | Around 100 units | Around 500 units | Around 1,000 units | What can override the tier |
|—|—|—|—|—|
| Formula | Proven base is lowest risk; limited adjustments only if technically and commercially feasible | Selected sensory, fragrance, color or ingredient-direction changes may be considered | Broader custom-development work may be practical | Batch size, raw-material minimums, stability and claim evidence |
| Primary packaging | Stock bottle, jar, tube, sachet or pouch | Wider stock range; selected color or finish options | More component colors, finishes or supplier routes | Component supplier MOQ, filling-line fit and compatibility |
| Decoration | Pressure-sensitive label or simple low-setup method | Label, carton and selected print methods | More direct-print or multi-component decoration choices | Print-process minimum, setup, registration and scrap allowance |
| Secondary packaging | Standard carton or no carton when lawful and commercially suitable | Custom printed carton is more likely to be viable | More finishes, inserts or coordinated sets may be possible | Carton-converter minimum, board, finish and manual assembly |
| Testing and documents | Must still match formula, pack, claims and market | Easier to spread fixed verification costs across units | Better fixed-cost absorption, but not lower regulatory responsibility | Destination market, product type, change scope and evidence needed |
| Best commercial use | Demand test, sampling, creator seeding or limited DTC launch | Controlled launch with stronger shelf presentation | First scalable run backed by demand evidence | Forecast quality, cash cycle, sell-through and expiry risk |

These tiers are planning scenarios, not universal quotations. Ask the manufacturer to price the same specification at multiple quantities and identify which feature creates each minimum.

## Why MOQ Is a System, Not One Number

The finished-goods MOQ is only one constraint. A cosmetic project may also have minimums for the bulk formula, active ingredients, bottle or sachet production, pump color, printing, cartons, labels and shipping cartons. The binding MOQ is the highest unavoidable minimum after practical stock options and surplus handling are considered.

For example, a filler may accept 500 units while a custom-colored pump supplier requires a larger component run. The brand must then buy surplus pumps, switch to a stock pump or increase the finished-goods order. A responsible quote makes that mismatch visible.

## What You Can Usually Customize at 100 Units

At approximately 100 units, customization should prove the commercial idea without creating unnecessary component inventory.

### Keep the formula route simple

The strongest route is often an eligible proven formula that already has a known manufacturing path. A custom fragrance, color or active direction may be possible in some projects, but even a small change can trigger new compatibility, stability, safety or claims questions. Treat every formula change as a technical change, not a menu selection.

### Use packaging that already exists

Stock components reduce purchasing minimums and remove mold development. The useful customization is then concentrated in artwork, label material, carton design and a coordinated color system. Confirm the component specification, fill quantity, closure, liner, pump output and available decoration area before approving graphics.

![A small set of unbranded stock cosmetic containers with blank labels on a product-development worktable](../../assets/blog/low-moq-cosmetics-manufacturing/100-unit-stock-packaging-launch.jpg)

*Illustrative concept showing a low-setup packaging route; not an INHI project or production record.*

## What You Can Usually Customize at 500 Units

Around 500 units, the project may support more differentiation, but the most valuable upgrades are those customers can recognize and operations can repeat.

### Add controlled formula differentiation

Selected changes to sensory profile, fragrance, appearance or ingredient direction may be practical when the technical team confirms raw-material availability and testing needs. Lock a measurable brief: benchmark, texture, absorption, finish, color, odor, fill size, use area and claims boundary. Avoid approving a formula solely because a sample feels good on the day it arrives.

### Improve the packaging system, not just the bottle

At this level, brands may evaluate a broader stock component family, printed cartons, label upgrades or selected decoration processes. The package must still work as a system. Formula-contact materials, closure torque, pump or sprayer performance, label adhesion, carton dimensions and shipping protection should be assessed together.

![Unbranded cosmetic bottle prototypes, material samples and color swatches arranged for formula and packaging review](../../assets/blog/low-moq-cosmetics-manufacturing/500-unit-formula-packaging-options.jpg)

*AI-generated editorial illustration of a development review; no text, claims or real client materials are shown.*

### Budget for evidence, not only inventory

Moving from a proven base to a changed formula or package can change the required verification scope. Clarify who pays for compatibility, stability, microbiological or other applicable testing; what constitutes acceptance; whether the quote includes retesting after a change; and which records the brand receives.

## What You Can Usually Customize at 1,000 Units

At approximately 1,000 units, more component sourcing and decoration options may open, but the brand should not add complexity simply because it can.

### Consider direct decoration selectively

Screen printing, hot stamping, coating or multi-pass decoration can require setup, color standards and scrap allowance. Ask for the minimum by component and by artwork, not only the final product MOQ. Approve physical samples under consistent lighting and retain an agreed color reference.

### Evaluate component color and finish

Custom or semi-custom colors may become more realistic through some suppliers, while proprietary molds and specialized pumps can remain above this tier. Confirm whether the color is molded, coated or printed; whether future batches can match it; and whether surplus components are owned, stored and traceable.

![Larger groups of unbranded cosmetic components, printed cartons without text and quality-review tools on a clean studio table](../../assets/blog/low-moq-cosmetics-manufacturing/1000-unit-decoration-quality-review.jpg)

*Editorial manufacturing concept; not an INHI factory, batch, inspection or customer order.*

### Build for repeatability

The objective at 1,000 units should be a repeatable commercial specification. Record the approved formula version, component codes, artwork revisions, color standards, finished-product specification, acceptance criteria, test plan, retained-sample requirements and change-control process. Reorders become risky when approval lives only in email threads and photos.

## Cost, MOQ and Timeline: What an Accurate Quote Must Show

There is no reliable universal unit price or lead time for “a 500-unit cosmetic.” A quote should separate at least:

1. Formula development or formula-use charges.
2. Bulk and filling cost.
3. Primary packaging and closures.
4. Labels, printing, decoration and cartons.
5. Tooling, plates, screens or molds when applicable.
6. Testing, safety and documentation support.
7. Freight, duties, taxes and the named delivery term.
8. Surplus components, scrap allowance and storage.

Ask for quantity breaks at 100, 500 and 1,000 units against one controlled specification. If the specification changes between breaks, the comparison is invalid.

For timing, request separate milestones for brief confirmation, sample dispatch, formula approval, compatibility or stability work, component production, artwork approval, filling, quality release and delivery. INHI’s public pages state that eligible samples can be prepared within seven days after the brief is confirmed and that qualified inquiries receive an initial response and quotation within 24 hours. Those statements do not replace a project-specific production schedule.

## Compliance Does Not Shrink with the Order

Low MOQ reduces inventory exposure; it does not automatically reduce legal responsibility.

For cosmetics marketed in the United States, FDA states that the responsible person must maintain adequate safety-substantiation records. MoCRA also establishes serious-adverse-event reporting, facility registration and product-listing requirements, with limited exemptions for certain small businesses and exceptions to those exemptions for specified product types. Eligibility must be assessed for the responsible person, facility and product; a small production run alone is not an exemption.

FDA’s labeling summary states that retail cosmetics generally require an ingredient declaration and that the principal display panel must identify the product and state net contents. Labeling must not be false or misleading. A small pack also creates practical artwork challenges because required information must remain legible.

For the European Union, the current consolidated Cosmetics Regulation requires a Responsible Person, good manufacturing practice, a safety assessment, a Product Information File and notification before market placement. Article 11 specifies that the PIF includes the cosmetic product safety report, manufacturing method and GMP statement, and evidence supporting claimed effects where justified.

ISO 22716 remains a current international guideline for production, control, storage and shipment. It does not replace destination-market law.

## Low-MOQ Project Process

Use this sequence to prevent a small launch from becoming an uncontrolled experiment:

1. **Define the market and product.** State destination country, channel, use area, user, claims boundary and target price.
2. **Choose the quantity’s purpose.** Decide whether the run validates demand, launches a channel or supports a reorderable SKU.
3. **Select the development route.** Compare proven formula, controlled modification and custom development.
4. **Match packaging to the tier.** Start with stock components; add decoration only when its minimum and repeatability are acceptable.
5. **Issue one specification-based RFQ.** Request identical quantity breaks and explicit exclusions.
6. **Approve formula and packaging together.** Define compatibility, stability, artwork and functional checks before production.
7. **Lock records and responsibilities.** Confirm specifications, tests, label owner, regulatory roles, change control and release documents.
8. **Review sell-through before scaling.** Use actual demand and complaint data to decide the next order.

INHI’s [beauty manufacturing Insights hub](https://inhicosmetics.com/insights/) provides additional planning guidance on MOQ, packaging, documentation and project briefs.

## Common Mistakes and Purchasing Risks

### Treating 100 units as “fully custom”

At low volume, full customization may require buying more formula or components than will be filled. Ask which elements are stock, modified or custom and what happens to any surplus.

### Comparing prices with different scopes

A label on a stock bottle is not equivalent to coated custom-colored packaging with direct printing. Use one bill of materials, one quality scope and one delivery term.

### Designing artwork before confirming the component

Artwork dimensions, print areas, label curvature and required copy depend on the final pack. Freeze the component and receive the correct dieline before final approval.

### Ignoring pack-formula compatibility

A visually attractive pump can leak, clog, discolor or deliver the wrong dose. Define functional acceptance and the intended test path before placing the production deposit.

### Scaling complexity before demand

More SKUs, fragrances and finishes multiply purchasing, testing, artwork and inventory risk. Scale the evidence-backed SKU first.

## Frequently Asked Questions

### Can I launch a private-label cosmetic with 100 units?

Yes, when the selected formula, packaging and process are eligible at that quantity. INHI publicly states that eligible proven-formula projects can start from 100 units. Confirm the exact SKU, pack, decoration, market and required documents before relying on that minimum.

### Can I get a custom formula at 100 units?

Possibly, but “custom” must be defined. A controlled adjustment is different from a new formula built around specialized raw materials, testing and claims. Ask the manufacturer to state what changes are technically feasible and what verification they trigger.

### Is 500 units enough for custom packaging?

Sometimes for stock packaging with custom labels, cartons or selected decoration. It may not be enough for a proprietary mold, specialized pump or custom material. The component supplier’s minimum can exceed the finished-product MOQ.

### Does ordering 1,000 units guarantee a lower total project cost?

No. Unit cost may fall because fixed work is spread across more units, while total cash outlay, freight, storage and unsold-inventory exposure rise. Compare landed cost and sell-through risk, not only ex-factory unit price.

### What should I ask a low-MOQ cosmetics manufacturer before paying a deposit?

Ask for the approved specification, formula route, component codes, finished-goods and component MOQs, surplus ownership, testing scope, documents, artwork approvals, payment milestones, change control, delivery term and project-specific schedule.

## Conclusion: Buy the Right Learning at the Right Quantity

Choose 100 units to validate with low setup, 500 units to add controlled differentiation, and 1,000 units to build a more repeatable presentation when demand supports it. The correct tier is the smallest quantity that can deliver a compliant, testable and commercially useful specification without creating hidden component commitments.

To evaluate one concrete product, send INHI the category, target market, quantity, benchmark, packaging direction and desired launch date through the [Start a Project brief](https://inhicosmetics.com/contact/). Ask for a single recommended route and quantity-break quotation; this is the article’s only conversion action.

## Sources and References

1. INHI Cosmetics, [Solutions](https://inhicosmetics.com/solutions/) — public development routes, eligible 100-unit starts and project flow. Accessed September 14, 2026.
2. INHI Cosmetics, [Insights](https://inhicosmetics.com/insights/) — public MOQ, sample and quotation statements. Accessed September 14, 2026.
3. INHI Cosmetics, [Start a Project](https://inhicosmetics.com/contact/) — public project inputs, eligibility limitations and sampling process. Accessed September 14, 2026.
4. U.S. Food and Drug Administration, [Modernization of Cosmetics Regulation Act of 2022](https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022-mocra) — responsible-person duties, safety substantiation, registration, listing, serious adverse events and exemptions. Accessed September 14, 2026.
5. U.S. Food and Drug Administration, [Summary of Cosmetics Labeling Requirements](https://www.fda.gov/cosmetics/cosmetics-labeling-regulations/summary-cosmetics-labeling-requirements) — ingredient declaration, principal display panel, net contents and truthful labeling. Accessed September 14, 2026.
6. European Union, [Regulation (EC) No 1223/2009 on Cosmetic Products, consolidated text](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02009R1223-20260518) — Responsible Person, GMP, safety assessment, PIF and notification requirements. Current consolidated version checked September 14, 2026.
7. International Organization for Standardization, [ISO 22716:2007 Cosmetics — Good Manufacturing Practices](https://www.iso.org/standard/36437.html) — current guidelines for production, control, storage and shipment. Accessed September 14, 2026.
8. Google Search Central, [Creating Helpful, Reliable, People-First Content](https://developers.google.com/search/docs/fundamentals/creating-helpful-content) — content-quality and sourcing guidance. Accessed September 14, 2026.

From Insight to Execution

Explore Our Capabilities

Build With INHI

Ready to Develop Your Skincare Brand?

Share your product idea, target market, formula requirements, packaging preferences, and estimated order quantity with our OEM/ODM team.

Start Your Project